Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd's wholly owned subsidiary, CARBOGEN AMCIS AG, has commissioned a new ground-mounted photovoltaic system at its Neuland site in Switzerland. The 1,200 kWp solar plant, covering 6,200 m² with 2,448 modules, is one of the most efficient in the Swiss Mittelland. This initiative underscores the company's commitment to sustainability and renewable energy, with the generated power primarily for on-site consumption to reduce CO₂ emissions. The project was a collaboration with IWB and Planeco. This marks a significant step in CARBOGEN AMCIS's sustainability strategy to improve energy efficiency and increase renewable energy use.

Dishman Carbogen Amcis Ltd has announced the closure of its trading window for directors, designated persons, and their immediate relatives. This closure is in effect from July 1, 2026, and aligns with SEBI's Prohibition of Insider Trading Regulations, 2015. The trading window will reopen 48 hours after the announcement of the company's unaudited financial results for the quarter ending June 30, 2026. This measure is standard practice to prevent potential insider trading ahead of financial results.

Dishman Carbogen Amcis Ltd announced the allotment of 1,800 Senior, Secured, Rated, Listed, Transferable, Redeemable, Taxable Non-Convertible Debentures (NCDs) worth ₹18 crore. The allotment was approved by the Management Committee of the Board of Directors on June 9, 2026, through private placement. These NCDs have a face value of ₹1,00,000 each and a final maturity date of December 9, 2027, or any early redemption date. This move signifies the company's ongoing efforts to raise capital through debt instruments.

Dishman Carbogen Amcis Ltd has announced an Extra-Ordinary General Meeting (EGM) to be held on June 19, 2026, at 3:00 p.m. IST via video conferencing. The EGM will address the increase in borrowing limits pursuant to Section 180(1)(c) of the Companies Act, 2013. Shareholders can vote remotely via e-voting from June 16 to June 18, 2026. The cut-off date for determining shareholders eligible to vote is June 12, 2026.

Dishman Carbogen Amcis Ltd has announced an Extra-Ordinary General Meeting (EGM) to be held on Friday, June 19, 2026, at 15:00 hrs IST via video conferencing. The EGM aims to obtain shareholder approval on special business matters, including increasing borrowing limits and availing a loan from a Promoter Group Entity under the External Commercial Borrowings (ECB) route as a Material Related Party Transaction. Details on attending the EGM and voting will be provided in the Notice of the EGM.

Dishman Carbogen Amcis Ltd's board meeting on May 19, 2026, will consider and approve the audited financial results for the quarter and year ended March 31, 2026. The board will also evaluate and approve a proposal to avail External Commercial Borrowing (ECB) of up to CHF 135 million from a promoter group company. This unsecured loan aims to refinance existing external debt at more favorable terms, including reduced interest costs, subject to shareholder and regulatory approvals. The trading window will open on May 22, 2026, after being closed from April 1 to May 21, 2026.

Dishman Carbogen Amcis Ltd's subsidiary, CARBOGEN AMCIS (Shanghai) Co. Ltd., successfully completed an unannounced Good Manufacturing Practice (GMP) inspection by China’s National Medical Products Administration (NMPA). The inspection, which included an on-site assessment of API manufacturing operations and the site’s Quality System, concluded without observations. This outcome validates the company's commitment to maintaining high GMP standards and reinforces confidence in the Shanghai site as a reliable partner for customers worldwide.

Dishman Carbogen Amcis Ltd has announced the appointment of Mr. Sandeep Jaiswal as Vice President (International Marketing), effective April 20, 2026. This appointment follows an induction program and is in line with the criteria approved by the Nomination and Remuneration Committee. Mr. Jaiswal brings over 27 years of experience in Business Development, Marketing, and Sales within the Active Pharmaceuticals Ingredients (API's), Speciality Chemicals, Intermediaries, and Food Activities sectors. His previous role was General Manager – Marketing at Apotex Pharmachem India PVT. LTD. This change in senior management is disclosed as per SEBI (LODR) Regulations, 2015.

Dishman Carbogen Amcis Ltd has received a letter from the Debenture Trustee, Axis Trustee Services Limited, regarding consent for amendment in terms related to financial covenants in respect of Non-Convertible Debentures (NCDs) issued by the company. The amendment is in connection with the 5,000 (Five thousand) Senior, Secured, Rated, Listed, Transferable, Taxable, Redeemable Non-Convertible Debentures of face value of Rs. 1,00,000/- (Rupees one lakh only) each, issued on private placement basis. The amendment is related to the Financial Covenants as per Clause 5.4 of Part B of the Debenture Trust Deed (DTD). The company has received a waiver for the Net Debt to Tangible Net Worth, Total Net Debt to EBIDTA, Adjusted Debt Service Coverage Ratio, and Interest Coverage Ratio for the Financial Year ended 31st March, 2026.

Dishman Carbogen Amcis Ltd has announced the closure of its trading window for all Directors, Designated Persons, and their immediate relatives, effective from 1st April, 2026. The closure is in accordance with the Code of Conduct for prevention of Insider Trading under SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will reopen 48 hours after the announcement of the Audited Financial Results for the quarter and year ending 31st March, 2026.